health
Chinese University Investigates 6-Year-Old's Death in Gene-Editing Trial
Archived — last updated
A Chinese university is investigating the death of a 6-year-old boy who was part of a gene-editing trial. The incident has raised concerns about the ethics of gene editing and the safety of participants in such trials.
Latest updates
Chinese University Investigates 6-Year-Old's Death in Gene-Editing Trial
A Chinese university is investigating the death of a 6-year-old boy who was part of a gene-editing trial. The incident has raised concerns about the ethics of gene editing and the safety of participants in such trials. According to reports, the boy was part of a gene-editing trial at the university, which aimed to develop a new treatment for a genetic disorder. However, the boy died after being administered the gene-editing treatment. The university has launched an investigation into the incident and has promised to take necessary action to ensure the safety of participants in such trials. The incident has sparked a debate about the ethics of gene editing and the need for stricter regulations to protect participants in such trials.
Chinese girl’s death exposes risks of unregulated gene-editing trials
A six-year-old girl in China died in March 2025 after receiving an experimental base-editing therapy for a rare brain disorder, according to an investigation by *Science* and Retraction Watch. The trial, claimed as the world’s first base-editing therapy directed at the brain, lacked proper oversight, raising ethical and regulatory concerns. Researchers had aimed to treat a genetic condition but failed to prevent fatal complications. The case has reignited debates over the regulation of experimental gene-editing trials in China.
China's gene-editing trial death sparks debate on unregulated science oversight
A six-year-old girl in China died in March 2025 after undergoing what researchers claimed was the world's first base-editing therapy directed at the brain. An investigation by Science and Retraction Watch revealed gaps in the oversight of the experimental trial, including the lack of proper regulatory approvals. The case has sparked a broader debate about the ethical and safety implications of unregulated gene-editing trials, particularly for rare but serious disorders. The researchers involved have not publicly addressed the investigation's findings.
Shanghai Jiao Tong University Medical School Vows Probe into Gene-Editing Trial Death
Shanghai Jiao Tong University medical school has vowed to conduct a thorough probe into the death of a 6-year-old girl who died after participating in a gene-editing trial. The trial was conducted at the university's medical school. According to the Global Times, the university has promised to investigate the incident and take necessary action. The exact details of the trial and the girl's death are not available, but it is clear that the university is taking the incident seriously. The Global Times reported that the university has a reputation for conducting cutting-edge medical research, but this incident has raised concerns about the safety of such trials. The university has promised to cooperate with the authorities and provide any necessary information.
Sources
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.